Two Sigma Securities’s bioAffinity Technologies BIAF Stock Holding History

Two Sigma Securities’s Portfolio BIAF Stock Details BIAF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,125	Closed	-$13.1K	–	1675
2025 Q4	$13.1K	Buy	+11,125	New	+$22.2K	﹤0.01%	1255
2025 Q1	–	Sell	-481	Closed	-$13.1K	–	1486
2024 Q4	$13.1K	Buy	+481	New	+$19.4K	﹤0.01%	1395

Other funds holding BIAF

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JSSH

J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

AAS

Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return

Two Sigma Securities's BIAF Position: Q1 2026 in Review

Two Sigma Securities sold out of bioAffinity Technologies (BIAF) in Q1 2026, closing a stake of 11,125 shares — an estimated $13.1K sold.

Two Sigma Securities first reported a position in BIAF in Q4 2024 and held it in 2 quarters. The position peaked at $13.1K in Q4 2025. 14 funds tracked by Wall St. Rank hold BIAF as of Q1 2026.

Two Sigma Securities reported no remaining bioAffinity Technologies position as of Q1 2026 after selling out during the quarter.
Two Sigma Securities sold 11,125 bioAffinity Technologies shares in Q1 2026, an estimated $13.1K.
Two Sigma Securities first reported a position in bioAffinity Technologies in Q4 2024 and held it in 2 quarters.
Two Sigma Securities's bioAffinity Technologies position peaked at $13.1K in Q4 2025.
14 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.